IL22RA1 and COVID-19: The numbers of IL-22R1+ myeloid DC1, myeloid DC2, and plasmacytoid DC and the proportions of IL-22R1+ intermediate, non-classical, and classical monocytes higher in COVID-19 patients than controls at the presented day.